These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3878708)

  • 21. Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice.
    Wambebe C
    Br J Pharmacol; 1985 Jan; 84(1):185-91. PubMed ID: 3156646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic activity of angiotensin II and its fragments Val-Tyr-Ile-NH2 and Val-Tyr-Ile-His-NH2.
    Własienko J; Braszko JJ; Koziołkiewicz W; Janecka A; Wiśniewski K
    Biomed Biochim Acta; 1989; 48(9):707-13. PubMed ID: 2619739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-L-tryptophan.
    Halladay AK; Wagner GC; Sekowski A; Rothman RB; Baumann MH; Fisher H
    Synapse; 2006 Apr; 59(5):277-89. PubMed ID: 16416445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment.
    Nabeshima T; Yamaguchi K; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1986 May; 24(5):1275-9. PubMed ID: 3725829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible link between brain serotonin metabolism and methionine sulfoximine-induced hypothermia and associated behavior in the rat.
    Ginefri-Gayet M; Gayet J
    Pharmacol Biochem Behav; 1992 Sep; 43(1):173-9. PubMed ID: 1409801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Methoxytryptamine-induced head twitches in rats.
    Przegaliński E; Zebrowska-Lupina I; Wójcik A; Kleinrok Z
    Pol J Pharmacol Pharm; 1977; 29(3):253-61. PubMed ID: 267911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors.
    Hutson PH; Donohoe TP; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(2):215-23. PubMed ID: 3113985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
    Friedman R; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of angiotensin on central effect of acetylcholine in rats.
    Malinowska L; Olszewski A; Buczko J
    Pol J Pharmacol Pharm; 1976; 28(6):685-90. PubMed ID: 1012989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postsynaptic action by four antidepressive drugs in an animal model of depression.
    Nagayama H; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1981 Jul; 15(1):125-30. PubMed ID: 6974869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological evaluation of two novel analogues of mianserin: 2-N-carboxamidinonormianserin (FCC5) and 2-N-carboxamidonormianserin (FCC13).
    Leitch IM; Rawlow A; Rechtman MP
    Clin Exp Pharmacol Physiol; 1992 Jan; 19(1):25-30. PubMed ID: 1352487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of the brain and gut immunoreactive dynorphin by the serotonin system.
    Majeed NH; Lasoń W; Przewłocka B; Przewłocki R
    Life Sci; 1985 Jul; 37(4):339-43. PubMed ID: 2861553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ergot drugs on serotonergic function: behavior and neurochemistry.
    Silbergeld EK; Hruska RE
    Eur J Pharmacol; 1979 Sep; 58(1):1-10. PubMed ID: 315322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of insulin on 5-methoxytryptamine-induced wet dog shake behavior in rats.
    Kleinrok Z; Juszkiewicz M
    Pol J Pharmacol Pharm; 1986; 38(5-6):443-8. PubMed ID: 3554184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of angiotensin II and angiotensin II-(4-8)-pentapeptide in rats.
    Braszko JJ; WŁasienko J; Kupryszewski G; Witczuk B; Wisniewski K
    Physiol Behav; 1988; 44(3):327-32. PubMed ID: 3222356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased sensitivity to serotonergic agonists after repeated electroconvulsive shock in rats.
    Wielosz M
    Pharmacol Biochem Behav; 1985 May; 22(5):683-7. PubMed ID: 2989938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhydrating effect of acute administration of angiotensin II in rats.
    Fregly MJ; Wilson KM; Rowland NE; Cade JR
    Pharmacol Biochem Behav; 1992 Jan; 41(1):183-8. PubMed ID: 1539068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of 5-hydroxy-N-acetyltryptophan, a putative synthetic precursor of N-acetylserotonin.
    Burns TG; Szechtman H; Brown GM; Snieckus V
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):359-63. PubMed ID: 6984517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral depression after intraventricular infusion of octopamine in rats.
    Chance WT; Bernardini AP; James JH; Edwards LL; Minnema K; Fischer JE
    Am J Surg; 1985 Nov; 150(5):577-84. PubMed ID: 2415012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.